Nothing Special   »   [go: up one dir, main page]

AU2001246703A1 - Dna immunization vectors - Google Patents

Dna immunization vectors

Info

Publication number
AU2001246703A1
AU2001246703A1 AU2001246703A AU4670301A AU2001246703A1 AU 2001246703 A1 AU2001246703 A1 AU 2001246703A1 AU 2001246703 A AU2001246703 A AU 2001246703A AU 4670301 A AU4670301 A AU 4670301A AU 2001246703 A1 AU2001246703 A1 AU 2001246703A1
Authority
AU
Australia
Prior art keywords
dna immunization
immunization vectors
vectors
dna
immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001246703A
Inventor
Vivienne Frances Cox
Michael Steward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adprotech PLC
Original Assignee
Adprotech PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adprotech PLC filed Critical Adprotech PLC
Publication of AU2001246703A1 publication Critical patent/AU2001246703A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001246703A 2000-04-08 2001-04-09 Dna immunization vectors Abandoned AU2001246703A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0008582 2000-04-08
GBGB0008582.9A GB0008582D0 (en) 2000-04-08 2000-04-08 DNA immunization vectors
PCT/GB2001/001599 WO2001077324A1 (en) 2000-04-08 2001-04-09 Dna immunization vectors

Publications (1)

Publication Number Publication Date
AU2001246703A1 true AU2001246703A1 (en) 2001-10-23

Family

ID=9889429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001246703A Abandoned AU2001246703A1 (en) 2000-04-08 2001-04-09 Dna immunization vectors

Country Status (5)

Country Link
US (1) US20040229827A1 (en)
EP (1) EP1272632A1 (en)
AU (1) AU2001246703A1 (en)
GB (1) GB0008582D0 (en)
WO (1) WO2001077324A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001092295A2 (en) * 2000-05-30 2001-12-06 University Of Toronto Ligands for cd21 and compositions thereof for modulating immune responses
GB0025229D0 (en) * 2000-10-14 2000-11-29 Adprotech Ltd Veterinary immunisation vectors
KR100453877B1 (en) 2001-07-26 2004-10-20 메덱스젠 주식회사 METHOD OF MANUFACTURING Ig-FUSION PROTEINS BY CONCATAMERIZATION, TNFR/Fc FUSION PROTEINS MANUFACTURED BY THE METHOD, DNA CODING THE PROTEINS, VECTORS INCLUDING THE DNA, AND CELLS TRANSFORMED BY THE VECTOR
GB0204154D0 (en) * 2002-02-22 2002-04-10 Adprotech Ltd Cat immunisation vectors
DK2044111T3 (en) 2006-06-21 2014-11-17 Musc Found For Res Dev OBJECTIVE TO COMPLEMENT FACTOR H FOR TREATMENT OF DISEASES
US9066925B2 (en) 2009-07-02 2015-06-30 Musc Foundation For Research Development Methods of stimulating liver regeneration
US9650447B2 (en) 2010-05-14 2017-05-16 The Regents Of The University Of Colorado, A Body Corporate Complement receptor 2 (CR2) targeting groups
CN103249432A (en) * 2010-06-22 2013-08-14 科罗拉多大学董事会,法人团体 Antibodies to the c3d fragment of complement component 3
US10413620B2 (en) 2012-08-17 2019-09-17 The Regents Of The University Of Colorado, A Body Corporate Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
AU2013302441B2 (en) 2012-08-17 2018-05-10 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for detecting complement activation
WO2017189281A1 (en) * 2016-04-27 2017-11-02 The Regents Of The University Of Michigan C3d cellular and acellular vaccines for the prevention and treatment of cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501755A (en) * 1986-11-04 1989-06-22 シントロ　コーポレイション Construction of synthetic DNA and its use in the synthesis of large polypeptides
US6018030A (en) * 1986-11-04 2000-01-25 Protein Polymer Technologies, Inc. Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
US5641648A (en) * 1986-11-04 1997-06-24 Protein Polymer Technologies, Inc. Methods for preparing synthetic repetitive DNA
JPH0829098B2 (en) * 1988-01-05 1996-03-27 寳酒造株式会社 Cell adhesion activity polypeptide
WO1993012257A1 (en) * 1991-12-12 1993-06-24 Hybritech Incorporated Enzymatic inverse polymerase chain reaction library mutagenesis
US5861285A (en) * 1994-09-16 1999-01-19 Tdk Corporation Fusion protein-bound magnetic particles for recombinant production and magnetic separation of polypeptides of interest
US5763733A (en) * 1994-10-13 1998-06-09 Enzon, Inc. Antigen-binding fusion proteins
GB9424631D0 (en) * 1994-12-06 1995-01-25 Lynxvale Ltd Modulating the immune response
JP5132851B2 (en) * 1997-08-05 2013-01-30 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） New immunoprotective influenza antigens and their use in vaccination
DE19756975A1 (en) * 1997-12-20 1999-06-24 Hoechst Marion Roussel De Gmbh Binding partners for inhibitors of cyclin-dependent kinases and their use for the search for inhibitors, for the diagnosis or for the therapy of a disease
GB9727512D0 (en) * 1997-12-31 1998-02-25 Adprotech Plc Fuzzy genes and their application in molecular adjuvants

Also Published As

Publication number Publication date
GB0008582D0 (en) 2000-05-31
EP1272632A1 (en) 2003-01-08
WO2001077324A1 (en) 2001-10-18
US20040229827A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
AU2001232054A1 (en) Vector
AU2001246703A1 (en) Dna immunization vectors
AU2002245107A1 (en) Improved biochip
AU2001242625A1 (en) Gene sequence
AU2001240103A1 (en) Reproduction-specific genes
AU2001264247A1 (en) GASC1 gene
AU2001288839A1 (en) Self-rearranging dna vectors
AU2001280674A1 (en) Mini-adenoviral vector system for vaccination
AU2001235616A1 (en) Immunostimulatory oligonucleotides
WO2001098454A8 (en) Human dna sequences
AU2001252390A1 (en) Nucleic acid immunization
AU2001285743A1 (en) Adipose-related gene
AU4672401A (en) Vectors
AU2002347346A1 (en) Dna vaccine
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2001258708A1 (en) Vectors for dna delivery
AU2001235617A1 (en) Immunostimulatory oligonucleotides
AU2001280789A1 (en) Non-viral linear dna vectors and methods for using the same
AU2001278777A1 (en) Irap-binding protein
AU2001276406A1 (en) Apoptosis-inducing dna sequences
AU2001229472A1 (en) Novel plasmid dna vectors
AU2001240424A1 (en) Immunization agent
AU2001290317A1 (en) Novel peptides
AU2002232822A1 (en) Nucleic acid-associated proteins
AU2002210985A1 (en) Pca2501 gene